At5g61990 Antibody

What is At5g61990 and why is it significant in plant research?

At5g61990 is a protein-coding gene in Arabidopsis thaliana (Mouse-ear cress), a widely used model organism in plant molecular biology. This gene appears to be involved in seed longevity pathways, making it significant for understanding mechanisms of seed viability and storage . The protein encoded by this gene serves as a valuable marker for studying plant reproduction and seed development processes. Research involving At5g61990 contributes to broader understanding of plant biology, particularly in seed conservation and agricultural applications.

What are the key specifications of commercially available At5g61990 Antibodies?

At5g61990 Antibodies are typically polyclonal antibodies raised in rabbits against recombinant Arabidopsis thaliana At5g61990 protein . These antibodies are commonly supplied in liquid form with a storage buffer consisting of 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . They undergo purification through antigen affinity methods and are primarily designed for research applications including ELISA and Western blotting . When properly stored at -20°C or -80°C, these antibodies maintain their reactivity specifically toward Arabidopsis thaliana targets.

What are the validated experimental applications for At5g61990 Antibody?

The At5g61990 Antibody has been validated for several experimental applications including:

• Western Blotting (WB): For detecting native and denatured At5g61990 protein in plant tissue extracts

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of the target protein

• Immunohistochemistry: Although not explicitly mentioned in the available data, polyclonal antibodies of this nature are often applicable

• Immunoprecipitation: For isolation of protein complexes involving At5g61990

These applications enable researchers to investigate protein expression patterns, protein-protein interactions, and localization of At5g61990 in plant tissues.

How should researchers optimize Western blotting protocols specifically for At5g61990 detection?

For optimal Western blot detection of At5g61990 protein, researchers should consider the following protocol optimizations:

• Sample Preparation:

  • Extract proteins from Arabidopsis tissues using a buffer containing protease inhibitors

  • Use fresh tissue when possible or ensure proper flash-freezing techniques for stored samples

  • Include reducing agents in the sample buffer as appropriate for the epitope recognition

• Gel Electrophoresis Parameters:

  • Use 10-12% polyacrylamide gels for optimal resolution

  • Load 20-50 μg of total protein per lane

  • Include positive and negative controls (wild-type vs. knockout samples)

• Transfer and Detection:

  • Optimize transfer conditions (25V overnight at 4°C often yields best results for plant proteins)

  • Block with 5% non-fat dry milk or BSA in TBST

  • Use the At5g61990 Antibody at 1:1000 to 1:2000 dilution (optimize through titration)

  • Incubate primary antibody overnight at 4°C for maximum sensitivity

  • Use appropriate secondary antibody (anti-rabbit IgG conjugated with HRP)

  • Consider enhanced chemiluminescence (ECL) detection for optimal sensitivity

• Validation Controls:

  • Include At5g61990 knockout/knockdown samples as negative controls

  • Consider overexpression samples as positive controls

  • Use internal loading controls (e.g., actin or tubulin) for normalization

What are the best practices for extracting and preserving protein samples from Arabidopsis tissues for At5g61990 detection?

Optimal protein extraction for At5g61990 detection requires careful consideration of tissue selection, extraction buffers, and sample preservation:

• Tissue Selection and Collection:

  • Select appropriate developmental stages where At5g61990 is expressed

  • Harvest tissues at consistent times to account for potential diurnal variations

  • Flash-freeze samples immediately in liquid nitrogen to prevent protein degradation

• Extraction Buffer Composition:

  • Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100

  • Add 1 mM EDTA as a chelating agent

  • Include 1 mM DTT or 5 mM β-mercaptoethanol as reducing agents

  • Add protease inhibitor cocktail (e.g., PMSF, leupeptin, aprotinin)

  • For phosphorylated proteins, include phosphatase inhibitors

• Extraction Procedure:

  • Grind frozen tissue to a fine powder in liquid nitrogen using mortar and pestle

  • Add extraction buffer (ratio of 3-5 mL per gram of tissue)

  • Homogenize thoroughly and incubate on ice for 30 minutes with occasional mixing

  • Centrifuge at 14,000 x g for 15 minutes at 4°C

  • Collect supernatant and quantify protein concentration using Bradford or BCA assay

• Sample Storage:

  • Aliquot samples to avoid freeze-thaw cycles

  • Store at -80°C for long-term preservation

  • Add glycerol (10% final concentration) for additional stability

  • Document storage conditions and duration for experimental reproducibility

How can researchers validate the specificity of At5g61990 Antibody for their particular experiments?

Validating antibody specificity is crucial for reliable research outcomes. For At5g61990 Antibody, consider these validation approaches:

• Genetic Controls:

  • Test the antibody on samples from At5g61990 knockout/knockdown lines

  • Include overexpression lines as positive controls

  • Compare wild-type expression patterns across different tissues

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess purified At5g61990 protein or immunogenic peptide

  • Perform parallel Western blots with blocked and unblocked antibody

  • Specific binding should be significantly reduced in the competition sample

• Multiple Antibody Validation:

  • Compare results using alternative antibodies against the same target

  • Use antibodies recognizing different epitopes of At5g61990

  • Correlate protein detection with RNA expression data (RT-PCR or RNA-seq)

• Cross-Reactivity Testing:

  • Test the antibody against close homologs of At5g61990

  • Examine potential cross-reactivity with proteins from other plant species

  • Perform immunoprecipitation followed by mass spectrometry to identify all binding partners

• Documentation of Controls:

  • Create a validation profile documenting all specificity tests

  • Include positive and negative control images in publications

  • Address any unexpected bands or patterns observed

How can At5g61990 Antibody be used in co-immunoprecipitation studies to identify protein interaction partners?

Co-immunoprecipitation (Co-IP) with At5g61990 Antibody can reveal valuable protein-protein interaction networks through this protocol:

• Sample Preparation:

  • Extract proteins using a gentle lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40)

  • Add protease and phosphatase inhibitors to preserve protein complexes

  • Maintain cold conditions (4°C) throughout the procedure

  • Pre-clear lysate with Protein A/G beads to reduce non-specific binding

• Immunoprecipitation:

  • Incubate 2-5 μg of At5g61990 Antibody with 500-1000 μg of protein lysate overnight at 4°C

  • Add pre-washed Protein A beads (for rabbit antibodies) and incubate for 2-4 hours

  • Collect immune complexes by gentle centrifugation (1000 x g, 2 min)

  • Wash beads 4-5 times with cold wash buffer (lysis buffer with reduced detergent)

  • Elute proteins by boiling in SDS sample buffer or using a gentle elution buffer

• Analysis of Interacting Partners:

  • Perform Western blot analysis with antibodies against suspected interacting proteins

  • For unbiased discovery, submit samples for mass spectrometry analysis

  • Compare results with IgG control immunoprecipitations to identify specific interactions

• Validation of Interactions:

  • Confirm interactions using reverse Co-IP with antibodies against identified partners

  • Validate biological relevance through functional assays

  • Consider proximity ligation assays or FRET for in vivo confirmation

What strategies can resolve inconsistent or weak At5g61990 detection in Western blotting?

When encountering weak or inconsistent At5g61990 detection, consider these troubleshooting approaches:

• Protein Extraction Enhancement:

  • Modify extraction buffer composition (try different detergents: CHAPS, digitonin)

  • Increase extraction time or use sonication to improve protein solubilization

  • Consider specialized extraction protocols for membrane-associated proteins

  • Verify protein integrity by Coomassie staining prior to Western blotting

• Antibody Optimization:

  • Titrate antibody concentration (try 1:500 to 1:5000 dilutions)

  • Extend primary antibody incubation (overnight at 4°C)

  • Test different blocking agents (milk vs. BSA)

  • Use high-sensitivity ECL substrates for detection

  • Consider signal amplification systems (biotin-streptavidin)

• Technical Parameters:

  • Optimize protein loading (50-100 μg may be necessary for low-abundance proteins)

  • Reduce transfer voltage but extend transfer time

  • Use PVDF membranes instead of nitrocellulose for better protein retention

  • Consider gradient gels for improved resolution

  • Adjust exposure times during imaging

• Sample-Related Solutions:

  • Check expression levels in different tissues or developmental stages

  • Consider treatments that might upregulate At5g61990 expression

  • Verify sample preparation conditions (reduce proteolysis)

  • Test fresh antibody aliquots to rule out antibody degradation

How can researchers quantitatively analyze At5g61990 expression levels across different developmental stages or stress conditions?

For quantitative analysis of At5g61990 expression across experimental conditions:

• Experimental Design Considerations:

  • Plan comprehensive sampling across all relevant developmental stages

  • Include biological replicates (minimum n=3) for statistical validity

  • Design appropriate stress treatments with time-course sampling

  • Include internal standards and loading controls for normalization

• Quantitative Western Blot Protocol:

  • Ensure equal protein loading through Bradford/BCA quantification

  • Include calibration curves using recombinant protein standards if available

  • Use digital imaging systems rather than film for linear dynamic range

  • Include housekeeping proteins (actin, tubulin) as loading controls

  • Process all samples simultaneously to minimize technical variation

• Data Analysis and Normalization:

  • Quantify band intensities using ImageJ or specialized software

  • Normalize target protein signals to loading controls

  • Apply appropriate statistical tests (ANOVA, t-test) based on experimental design

  • Consider regression analysis for time-course experiments

  • Present data as fold-change relative to control conditions

• Complementary Approaches:

  • Validate protein levels with mRNA expression (qRT-PCR)

  • Consider ELISA for more precise quantification

  • Use immunohistochemistry to assess spatial distribution changes

  • Implement proteomic approaches for global protein dynamics

How can At5g61990 antibody-based studies be correlated with transcriptomic data to understand gene-protein expression relationships?

Integrating antibody-based protein detection with transcriptomics requires careful experimental design and analysis:

• Coordinated Sampling Strategy:

  • Collect samples for both protein and RNA analysis from the same experimental material

  • Process samples in parallel to maintain comparability

  • Document all metadata (growth conditions, developmental stage, time of day)

  • Maintain consistent handling to minimize technical variation

• Transcriptome Analysis Methods:

  • Perform RNA-seq or microarray analysis for genome-wide expression

  • Use qRT-PCR for targeted validation of At5g61990 mRNA levels

  • Include reference genes for normalization (e.g., PP2A, UBQ10)

  • Analyze splice variants that might affect protein detection

• Protein-RNA Correlation Analysis:

  • Generate time-course profiles of both mRNA and protein levels

  • Calculate correlation coefficients (Pearson or Spearman)

  • Apply time-lag analysis to account for delays between transcription and translation

  • Identify conditions where protein and mRNA levels diverge (post-transcriptional regulation)

• Data Integration and Visualization:

  • Create integrated heatmaps showing both protein and mRNA changes

  • Develop fold-change plots comparing protein vs. mRNA responses

  • Use principal component analysis to identify patterns across multiple conditions

  • Apply pathway analysis to contextualize At5g61990 within biological networks

What immunohistochemistry protocols are most effective for localizing At5g61990 protein in plant tissues?

For optimal immunolocalization of At5g61990 in plant tissues:

• Tissue Fixation and Embedding:

  • Fix fresh tissues in 4% paraformaldehyde in PBS for 12-24 hours at 4°C

  • Dehydrate gradually through ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

  • Clear with xylene or xylene substitute

  • Embed in paraffin or consider cryo-embedding for sensitive epitopes

  • Section at 5-10 μm thickness

• Antigen Retrieval and Blocking:

  • Deparaffinize and rehydrate sections

  • Perform antigen retrieval (citrate buffer pH 6.0, microwave treatment)

  • Block endogenous peroxidases with 3% H₂O₂ if using HRP detection

  • Block non-specific binding with 5% normal serum in PBS with 0.1% Triton X-100

  • Include avidin/biotin blocking if using biotinylated secondary antibodies

• Antibody Incubation and Detection:

  • Apply At5g61990 Antibody at 1:50 to 1:200 dilution overnight at 4°C

  • Wash thoroughly with PBS (3 × 5 minutes)

  • Apply appropriate secondary antibody (1:200 to 1:500) for 1-2 hours

  • For fluorescence, use fluorophore-conjugated secondary antibodies

  • For enzymatic detection, use HRP-conjugated antibodies with DAB substrate

  • Counterstain nuclei with DAPI for fluorescence or hematoxylin for brightfield

  • Mount in appropriate medium with anti-fade agent for fluorescence

• Controls and Validation:

  • Include negative controls (primary antibody omission, pre-immune serum)

  • Use tissue from At5g61990 knockout plants as specificity control

  • Compare localization patterns with in situ hybridization results

  • Document microscopy settings for reproducibility

How can researchers effectively use At5g61990 Antibody in chromatin immunoprecipitation (ChIP) studies if the protein has DNA-binding properties?

If At5g61990 functions as a DNA-binding protein, ChIP can be adapted with these considerations:

• Chromatin Preparation:

  • Cross-link plant tissue with 1% formaldehyde for 10-15 minutes

  • Quench with 0.125 M glycine for 5 minutes

  • Extract nuclei using buffer containing 0.25 M sucrose, 10 mM Tris-HCl pH 8.0, 10 mM MgCl₂, 1% Triton X-100

  • Shear chromatin to 200-500 bp fragments using sonication or enzymatic digestion

  • Verify fragment size by agarose gel electrophoresis

• Immunoprecipitation:

  • Pre-clear chromatin with Protein A/G beads

  • Incubate 5-10 μg of At5g61990 Antibody with chromatin overnight at 4°C

  • Add pre-blocked Protein A beads and incubate for 2-3 hours

  • Perform stringent washing (low salt, high salt, LiCl, and TE buffers)

  • Elute protein-DNA complexes and reverse cross-links (65°C overnight)

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or column purification

• Analysis Methods:

  • Perform qPCR for known or predicted target sequences

  • For unbiased discovery, prepare libraries for ChIP-seq

  • Include input chromatin and IgG controls for normalization

  • Apply appropriate peak-calling algorithms for ChIP-seq data analysis

• Validation Approaches:

  • Confirm binding with electrophoretic mobility shift assays (EMSA)

  • Validate functional relevance through reporter gene assays

  • Compare binding sites with differentially expressed genes in At5g61990 mutants

  • Analyze binding motifs for consensus sequences

How should researchers address conflicting results between antibody-based detection and genetic expression data for At5g61990?

When antibody-based protein detection conflicts with genetic data:

• Systematic Validation Process:

  • Verify antibody specificity through additional controls

  • Confirm genetic knockout/knockdown efficiency at both RNA and protein levels

  • Test multiple antibody lots and sources if available

  • Examine whether post-translational modifications affect antibody recognition

• Biological Explanations for Discrepancies:

  • Consider post-transcriptional regulation (miRNA, RNA stability)

  • Investigate protein turnover rates and stability factors

  • Examine potential epitope masking through protein interactions

  • Assess subcellular localization changes that might affect extraction efficiency

• Technical Reconciliation Approaches:

  • Try alternative protein extraction methods for difficult samples

  • Use multiple detection techniques (Western blot, ELISA, immunofluorescence)

  • Quantify absolute protein amounts through MRM-MS if possible

  • Cross-validate with epitope-tagged versions of At5g61990

• Data Integration Framework:

  • Develop a comprehensive model explaining discrepancies

  • Present all conflicting data transparently in publications

  • Propose testable hypotheses to resolve contradictions

  • Consider recruiting collaborators with complementary expertise

What considerations are important when comparing At5g61990 protein levels across different Arabidopsis ecotypes?

When comparing At5g61990 across ecotypes, researchers should account for:

• Genetic Variation Considerations:

  • Sequence the At5g61990 gene across studied ecotypes to identify polymorphisms

  • Check for variations in epitope regions that might affect antibody recognition

  • Assess copy number variations that could impact expression levels

  • Examine promoter variations that might cause expression differences

• Experimental Design Requirements:

  • Grow all ecotypes under identical controlled conditions

  • Harvest tissues at equivalent developmental stages rather than chronological age

  • Include common reference ecotypes (Col-0, Ler) in all experiments

  • Increase biological replication (n≥5) to account for natural variation

• Data Normalization Strategies:

  • Use multiple reference proteins for normalization

  • Verify that housekeeping genes maintain consistent expression across ecotypes

  • Consider relative quantification rather than absolute comparisons

  • Prepare mixed-ecotype internal standards for technical normalization

• Interpretation Framework:

  • Correlate protein level differences with phenotypic variations

  • Integrate with available natural variation datasets

  • Consider evolutionary and ecological context of observed differences

  • Apply statistical methods appropriate for multi-ecotype comparisons (nested ANOVA)

How can researchers distinguish between specific and non-specific signals when using At5g61990 Antibody in complex plant extracts?

To distinguish specific from non-specific signals:

• Control Experiments:

  • Use genetic knockout lines as negative controls

  • Perform peptide competition assays to block specific binding

  • Include pre-immune serum controls

  • Compare signals across multiple tissues with known expression patterns

• Signal Validation Techniques:

  • Verify that the detected band is at the expected molecular weight

  • Look for consistency in signal patterns across experimental replicates

  • Test different antibody concentrations to identify specific vs. non-specific signals

  • Compare detection patterns across different experimental conditions

• Enhanced Purification Approaches:

  • Consider immunoprecipitation before Western blotting

  • Use subcellular fractionation to enrich for relevant compartments

  • Apply additional purification steps to reduce sample complexity

  • Use 2D gel electrophoresis for improved resolution

• Analytical Confirmation:

  • Excise and identify bands by mass spectrometry

  • Correlate protein detection with corresponding mRNA levels

  • Use alternative antibodies targeting different epitopes of At5g61990

  • Apply orthogonal detection methods (activity assays if applicable)

How might At5g61990 Antibody be adapted for use in high-throughput phenotyping or screening applications?

Adapting At5g61990 Antibody for high-throughput applications:

• Assay Miniaturization Strategies:

  • Develop microplate-based ELISA formats (384-well)

  • Create dot blot arrays for rapid screening

  • Adapt to automated Western blot systems

  • Design multiplex detection systems incorporating At5g61990 and other markers

• Automation Implementation:

  • Interface with liquid handling robots for sample preparation

  • Develop standardized extraction protocols compatible with automation

  • Create reference standards for calibration across plates/batches

  • Implement quality control metrics for assay validation

• Data Acquisition and Analysis:

  • Develop image analysis algorithms for automated quantification

  • Create machine learning models for pattern recognition

  • Implement database systems for result storage and retrieval

  • Design visualization tools for multi-dimensional data exploration

• Application Scenarios:

  • Screen germplasm collections for At5g61990 expression variation

  • Monitor protein responses across environmental gradients

  • Evaluate transgenic lines for desired expression patterns

  • Assess chemical compound effects on At5g61990 levels or modifications

What approaches can integrate At5g61990 protein studies with metabolomic analyses to understand its role in plant biochemical networks?

Integrating protein studies with metabolomics requires:

• Coordinated Experimental Design:

  • Collect samples simultaneously for protein and metabolite extraction

  • Include time-course sampling to capture dynamic relationships

  • Design perturbation experiments targeting At5g61990 function

  • Include appropriate controls for both protein and metabolite analyses

• Metabolomic Analysis Methods:

  • Perform untargeted metabolite profiling using LC-MS or GC-MS

  • Develop targeted assays for metabolites in relevant pathways

  • Include internal standards for quantification

  • Apply appropriate extraction methods for diverse metabolite classes

• Data Integration Strategies:

  • Calculate correlation networks between At5g61990 levels and metabolites

  • Apply multivariate statistical methods (PCA, PLS-DA, OPLS)

  • Use pathway enrichment analysis to identify affected biochemical processes

  • Develop visualizations showing protein-metabolite relationships

• Functional Validation:

  • Test hypothesized relationships through targeted genetic manipulation

  • Perform in vitro assays with purified At5g61990 protein and metabolites

  • Use isotope labeling to track metabolic flux in wildtype vs. mutant plants

  • Validate findings in multiple genetic backgrounds

How can researchers effectively use At5g61990 Antibody in studying protein-protein interaction networks through advanced proteomics approaches?

Advanced proteomics approaches for interaction networks:

• Proximity-Dependent Labeling:

  • Fuse At5g61990 with BioID or TurboID biotin ligase

  • Express fusion protein in Arabidopsis

  • Perform streptavidin pulldown of biotinylated proteins

  • Identify interacting partners by mass spectrometry

  • Validate interactions using At5g61990 Antibody in co-IP experiments

• Cross-Linking Mass Spectrometry (XL-MS):

  • Apply protein cross-linkers to intact plant tissues

  • Immunoprecipitate At5g61990 using specific antibody

  • Digest and analyze by LC-MS/MS

  • Identify cross-linked peptides to map interaction interfaces

  • Model structural relationships between At5g61990 and partners

• Native Complex Analysis:

  • Extract protein complexes under non-denaturing conditions

  • Separate by blue native PAGE or size exclusion chromatography

  • Detect At5g61990 in fractions using specific antibody

  • Identify co-migrating proteins by mass spectrometry

  • Reconstruct complex composition and stoichiometry

• Quantitative Interaction Proteomics:

  • Compare At5g61990 interactomes across developmental stages

  • Use SILAC, TMT, or label-free quantification

  • Apply computational network analysis

  • Identify dynamic changes in interaction partners

  • Correlate with functional phenotypes

This integrated approach provides a framework for comprehensive characterization of At5g61990's functional role within protein interaction networks.

How might CRISPR-engineered variants of At5g61990 be used alongside antibody-based detection to understand protein function?

Integrating CRISPR engineering with antibody detection:

• Epitope Tagging Strategies:

  • Use CRISPR/Cas9 to introduce small epitope tags (FLAG, HA, V5)

  • Position tags to minimize functional disruption

  • Create C-terminal and N-terminal tagged variants

  • Compare native protein detection (At5g61990 Antibody) with tag detection

  • Validate tag impact on protein function through complementation tests

• Domain Function Analysis:

  • Generate CRISPR deletions of specific functional domains

  • Assess effects on protein stability, localization, and interactions

  • Use At5g61990 Antibody to verify truncated protein expression

  • Compare binding properties of wild-type and variant proteins

  • Create domain swap chimeras to test functional hypotheses

• Post-Translational Modification Studies:

  • Mutate putative modification sites (phosphorylation, ubiquitination)

  • Generate phosphomimetic or phospho-null variants

  • Use modification-specific antibodies alongside At5g61990 Antibody

  • Assess impact on protein function and interactions

  • Map regulatory networks controlling protein activity

• Experimental Applications:

  • Create allelic series with graduated functional impacts

  • Develop reporter fusions for live imaging

  • Generate conditional expression systems

  • Establish orthogonal labeling approaches for multiplexed detection

What considerations are important when developing a monoclonal antibody against At5g61990 for improved specificity?

Developing monoclonal antibodies with enhanced specificity requires:

• Antigen Design Strategies:

  • Select unique regions of At5g61990 with low homology to related proteins

  • Consider both linear epitopes and conformational determinants

  • Produce recombinant protein under native conditions when possible

  • Verify proper folding through biochemical and biophysical characterization

  • Design peptide antigens conjugated to carrier proteins for small epitopes

• Immunization and Screening Protocol:

  • Immunize mice or rats with purified antigen

  • Establish robust screening assays using both recombinant and native protein

  • Screen hybridoma supernatants against multiple plant species extracts

  • Include knockout/knockdown samples in screening process

  • Select clones with high specificity and suitable affinity

• Validation Requirements:

  • Characterize epitope binding through epitope mapping

  • Test cross-reactivity against close homologs

  • Evaluate performance across multiple applications (WB, IP, IHC)

  • Assess batch-to-batch consistency

  • Determine optimal working conditions for each application

• Production and Quality Control:

  • Establish stable hybridoma cell lines

  • Implement rigorous purification protocols

  • Develop quantitative specificity assays

  • Determine shelf-life and storage conditions

  • Create validation data packages for research community

How might structural biology approaches combined with At5g61990 Antibody studies advance understanding of protein function?

Integrating structural biology with antibody studies:

• Antibody-Facilitated Structural Analysis:

  • Use At5g61990 Antibody for immunoaffinity purification of native protein

  • Employ antibody fragments (Fab) to stabilize flexible regions for crystallization

  • Generate antibody-protein complexes for structural studies

  • Apply single-particle cryo-EM for large complexes

  • Use antibodies to verify structural elements in native context

• Structure-Function Relationship Studies:

  • Map antibody epitopes to structural domains

  • Correlate functional impacts with structural features

  • Identify critical residues for activity through mutagenesis

  • Develop structure-based hypotheses for protein interactions

  • Create molecular models integrating experimental constraints

• Dynamic Structural Analysis:

  • Use antibodies to trap specific conformational states

  • Apply hydrogen-deuterium exchange mass spectrometry for dynamics

  • Investigate ligand-induced conformational changes

  • Study protein-protein interaction interfaces

  • Develop conformational state-specific antibodies

• Application to Biological Questions:

  • Investigate structural basis of At5g61990's role in seed longevity

  • Examine structural changes during stress responses

  • Characterize interaction surfaces with partner proteins

  • Identify allosteric regulation mechanisms

  • Develop structure-guided protein engineering strategies